Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5671821 | Clinical Microbiology and Infection | 2017 | 32 Pages |
Abstract
Rapid identification of contaminated BCs (n = 126) resulted in a shorter duration of intravenous antimicrobial therapy (mean 4.8 versus 7.5 days, p 0.04). Rapid identification using MALDI-TOF directly from positive BCs did not impact on duration of intravenous antimicrobial therapy, but provided fast and reliable microbiological results and may improve treatment quality in the setting of an established ASP.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Osthoff, N. Gürtler, S. Bassetti, G. Balestra, S. Marsch, H. Pargger, M. Weisser, A. Egli,